July 30 (Reuters) - Australian hospital group Healthscope Ltd (HSO) said on Monday it will sell its Asian pathology business for A$279 million ($206.5 million) to entities controlled by funds which are managed by TPG Capital Asia.
The Melbourne-based company had flagged the sale of the operations which consist of 39 pathology laboratories across Singapore, Malaysia and Vietnam in May.
($1 = 1.3510 Australian dollars)
July 30 (Reuters) - Australian hospital group Healthscope Ltd...
Add to My Watchlist
What is My Watchlist?